Panuveitis, granulomatous inflammation, and ocular complications significantly increase the risk of poor visual outcomes. These patients require closer monitoring and early immunosuppressive treatment.
de-la-Torre et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: